The PCA score plot demonstrated a clear trend of separation between CML patients and NC subjects, primarily along PC1, which accounted for 57% of the total variance, followed by PC2 (11.4%) ( Figure A).
← all excerpts
Clinico-Metabolic Profiling Unraveled Key Metabolic Alterations Underlying the Pathophysiology of Chronic Myeloid Leukemia.
1
—
—